The effect of continuous normalization of serum ch 50 on the course of lupus nephritis a 5 year prospective study
Jarrett, M.P.; Walter, L.; Barland, P.; Sablay, L.; Golden, R.; Bank, N.; Grayzel, A.I.
Arthritis and Rheumatism 23(6): 697
1980
ISSN/ISBN: 2326-5191
Accession: 029325726
PDF emailed within 1 workday: $29.90
Related References
Jarrett, M.P.; Sablay, L.B.; Walter, L.; Barland, P.; Grayzel, A.I. 1981: The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis: a five year prospective study American Journal of Medicine 70(5): 1067-1072Appel, A.E.; Sablay, L.B.; Golden, R.A.; Barland, P.; Grayzel, A.I.; Bank, N. 1978: The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study American Journal of Medicine 64(2): 274-283
Nossent, H.C.; Swaak, T.J. 1990: Effect of continuous normalization of serum complement levels on clinically evident lupus nephritis American Journal of Medicine 89(1): 125
Reid, S.E.; Anzarut, A. 1989: Neurosyphilis and stroke in a patient with antibodies to the human immunodefiency virus The American Journal of Medicine 87: 119-121
Laitman, R.S.; Glicklich, D.; Sablay, L.B.; Grayzel, A.I.; Barland, P.; Bank, N. 1989: Effect of long-term normalization of serum complement levels on the course of lupus nephritis American Journal of Medicine 87(2): 132-138
Moroni, G.; Radice, A.; Giammarresi, G.; Quaglini, S.; Gallelli, B.; Leoni, A.; Li Vecchi, M.; Vecchi, M.L.; Messa, P.; Sinico, R.A. 2009: Are laboratory tests useful for monitoring the activity of lupus nephritis? a 6-year prospective study in a cohort of 228 patients with lupus nephritis Annals of the Rheumatic Diseases 68(2): 234-237
Glicklich, D.; Laitman, R.; Sablay, L.; Bank, N.; Barland, P.; Grayzel, A. 1989: Effect of long term normalization of complement ch 50 on the course of lupus nephritis ln Arthritis and Rheumatism 32(4 Suppl): S74
Doria, A.; Piccoli, A.; Vesco, P.; Vaccaro, E.; Marson, P.; De Silvestro, G.; Ossi, E.; Gambari, P. 1994: Therapy of lupus nephritis. a two-year prospective study Annales de Medecine Interne 145(5): 307-311
Glas-Greenwalt, P.; Kant, K.S.; Dosekun, A.; Frazier, J.; Allen, C.; Pollak, V.E. 1985: Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis Journal of Laboratory and Clinical Medicine 105(1): 99-107
Cai, X.-Y.; Yang, X.-Y.; Chen, X.-H.; Liang, L.-Q.; Guan, M.-M.; Qin, S.-G.; Fu, J.-Z. 2004: Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis Zhonghua Yi Xue Za Zhi 84(17): 1436-1439
Valeri, A.; Radhakrishnan, J.; Estes, D.; D'Agati, V.; Kopelman, R.; Pernis, A.; Flis, R.; Pirani, C.; Appel, G.B. 1994: Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study Clinical Nephrology 42(2): 71-78
Garcia Carrasco, M.; Font, J.; Jimenez, S.; Ramos Casals, M.; Cervera, R.; Nonell, F.; Siso, A.; Torras, A.; Darnell, A.; Ingelmo, M. 1999: 10-Year prospective study of morbidity and mortality in a cohort of 70 patients with lupus nephritis followed-up in a single center Arthritis and Rheumatism 42(9 Suppl): S99
Domingues, V.; Levinson, B.A.; Bornkamp, N.; Goldberg, J.D.; Buyon, J.; Belmont, H.M. 2018: Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis Lupus Science and Medicine 5(1): E000271
Kuroki, A.; Shibata, T.; Honda, H.; Totsuka, D.; Kobayashi, K.; Sugisaki, T. 2002: Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy Internal Medicine 41(11): 936-942
Ren, Y.; Xie, J.; Lin, F.; Luo, W.; Zhang, Z.; Mao, P.; Zhong, R.; Liang, Y.; Yang, Z. 2018: Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: a prospective cohort study International Immunopharmacology 60: 189-193